IGF1 and sarcopenia: In this study, we demonstrated that the prevalence of sarcopenia among the patients with LC was 28.6% and confirmed our previous findings that lower serum levels of BCAA and IGF-1 were significantly and independently associated with sarcopenia in patients with LC [4].